foxo4-dri senolytic peptide animal study FOXO4-DRI: Human Trial Status, Cancer Research & Data Peptide inhibitors targeting FOXO4-p53 interactions
Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOX04 DRI (Proxofim) Anti Aging & Longevity, Targeted Senolytic Action, Age Related Diseases Peptide Buy Online Okdermo FOXO4 DRI (Proxofim) (10mg) Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine
Pay in 4 interest-free payments of $5.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27



